Interferon-γ receptor 1 promoter polymorphisms:: population distribution and functional implications

被引:33
作者
Rosenzweig, SD
Schäffer, AA
Ding, L
Sullivan, R
Enyedi, B
Yim, JJ
Cook, JL
Musser, JM
Holland, SM
机构
[1] NIAID, Immunopathogenesis Sect, Host Def Lab, NIH,DHHS, Bethesda, MD 20892 USA
[2] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, DHHS, Bethesda, MD 20892 USA
[3] Univ Illinois, Infect Dis Sect, Dept Med, Chicago, IL 60607 USA
[4] NIAID, Lab Human Bcterial Pathogenesis, NIH, DHHS, Hamilton, MT 59840 USA
关键词
single nucleotide polymorphisms; mycobacteria; pulmonary; disseminated; haplotype; avium;
D O I
10.1016/j.clim.2004.03.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Different polymorphisms have been described in the minimal promoter region (MPR) of the interferon-gamma receptor 1 (IFNGR1), a molecule that plays a critical role in mycobacterial control. We sequenced the IFNGR1 MPR from African American, Caucasian and Korean controls, and from mycobacteria-infected patients. Six different single nucleotide polymorphisms (SNPs) were detected in the IFNGR1 MPR. The three ethnic groups showed different SNP distribution patterns, but no significant differences were detected between mycobacterial cases and controls. Two polymorphisms were found in all populations (G-611A, T-56C). We cloned the four allelic variants (var) of haplotype G-611A/T-56C into a luciferase reporter vector and determined their promoter activity. Polymorphisms at position -611 had a stronger effect on the promoter activity than those at position -56, and constructs carrying G-611 produced a stronger promoter activity than -611A constructs. The IFNGR1 MPR is a polymorphic region with at least two SNPs influencing its activity, but these are not associated with increased mycobacterial susceptibility. Published by Elsevier Inc.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 24 条
[1]   Transcription factor AP-4 is a ligand for immunoglobulin-κ promoter E-box elements [J].
Aranburu, A ;
Carlsson, R ;
Persson, C ;
Leanderson, T .
BIOCHEMICAL JOURNAL, 2001, 354 :431-438
[2]   Characterization of single-nucleotide polymorphisms in coding regions of human genes [J].
Cargill, M ;
Altshuler, D ;
Ireland, J ;
Sklar, P ;
Ardlie, K ;
Patil, N ;
Lane, CR ;
Lim, EP ;
Kalyanaraman, N ;
Nemesh, J ;
Ziaugra, L ;
Friedland, L ;
Rolfe, A ;
Warrington, J ;
Lipshutz, R ;
Daley, GQ ;
Lander, ES .
NATURE GENETICS, 1999, 22 (03) :231-238
[3]   Genetic dissection of immunity to mycobacteria: The human model [J].
Casanova, JL ;
Abel, L .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :581-620
[4]   Population genetics - making sense out of sequence [J].
Chakravarti, A .
NATURE GENETICS, 1999, 21 (Suppl 1) :56-60
[5]   Interferon-γ and interleukin-12 pathway defects and human disease [J].
Dorman, SE ;
Holland, SM .
CYTOKINE & GROWTH FACTOR REVIEWS, 2000, 11 (04) :321-333
[6]   Genetic analysis of case/control data using estimated haplotype frequencies: Application to APOE locus variation and Alzheimer's disease [J].
Fallin, D ;
Cohen, A ;
Essioux, L ;
Chumakov, I ;
Blumenfeld, M ;
Cohen, D ;
Schork, NJ .
GENOME RESEARCH, 2001, 11 (01) :143-151
[7]   TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE [J].
FLYNN, JL ;
GOLDSTEIN, MM ;
CHAN, J ;
TRIEBOLD, KJ ;
PFEFFER, K ;
LOWENSTEIN, CJ ;
SCHREIBER, R ;
MAK, TW ;
BLOOM, BR .
IMMUNITY, 1995, 2 (06) :561-572
[8]   Interferon-γ receptor-1 gene polymorphism in tuberculosis patients from Croatia [J].
Fraser, DA ;
Bulat-Kardum, L ;
Knezevic, J ;
Babarovic, P ;
Matakovic-Mileusnic, N ;
Dellacasagrande, J ;
Matanic, D ;
Pavelic, J ;
Beg-Zec, Z ;
Dembic, Z .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (05) :480-484
[9]   Inference of haplotypes from samples of diploid populations: Complexity and algorithms [J].
Gusfield, D .
JOURNAL OF COMPUTATIONAL BIOLOGY, 2001, 8 (03) :305-323
[10]  
Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68